SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E. A. Kline who wrote (1426)2/1/2000 7:56:00 AM
From: CMon   of 1432
 
Your point in paragraph one has been the short thesis in this stock all along.

As for the royalty arrangmeent, it is not a good deal for Biotime in that they get a small part of sales until unrealistically large sales numbers are met.

And the idea that because ABT reports sales after a quarter is complete, and that Biotime will then only report those sales the following quarter, is a crock. We are supposed to believe that the company can't find out how their product is selling, and even then that they will hold what information they do have for months before telling shareholders? Give us a break!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext